High-Intensity Interval Training Improves Cardiorespiratory Fitness After Stroke

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Aug. 9, 2024 -- For individuals after stroke, 12 weeks of short-interval high-intensity interval training (HIIT) is effective for improving cardiorespiratory fitness (V̇O2peak), according to a study published online Aug. 8 in Stroke

Kevin Moncion, P.T., Ph.D., from McMaster University in Hamilton, Ontario, Canada, and colleagues conducted a multisite, 12-week randomized controlled trial with eight-week follow-up to compare the effects of 12 weeks of short-intensity HIIT versus moderate-intensity continuous training (MICT) among individuals at least six months poststroke. A total of 82 participants were randomly assigned to three days/week of HIIT or MICT (42 and 40 participants, respectively).

The researchers observed no adverse events during the study period. There was a significant group x study time point interaction for V̇O2peak at 12 weeks (mean difference, 1.81), with greater gains for the HIIT group versus the MICT group (Δ3.52 versus Δ1.71 mL/kg/min). At the eight-week follow-up, there was no between-group difference seen in V̇O2peak. There were no group x study time point interactions observed for cardiovascular risk factors or mobility outcomes.

"Given that a lack of time is a significant barrier to the implementation of aerobic exercise in stroke clinical practice, our findings suggest that short-interval HIIT may be an effective alternative to traditional MICT for improving V̇O2peak after stroke, with potential clinically meaningful benefits sustained in the short-term," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-08-10 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords